NCT04893577View on ClinicalTrials.gov

EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 20, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2025

Conditions
Herpes Simplex Oral
Interventions
DRUG

EDTA

Patients will treat their cold sore with EDTA eye drops based upon their randomization.

DRUG

Abreva

Patients will treat their cold sore with Abreva based upon their randomization

Trial Locations (1)

84107

University of Utah MidValley Dermatology, Murray

All Listed Sponsors
lead

University of Utah

OTHER